Correction: Ruxolitinib sensitizes ovarian cancer to reduced dose Taxol, limits tumor growth and improves survival in immune competent mice

• Type of Material: Article
• Authors: Patrick M. Reeves, Massachusetts General Hospital; Mojgan A. Abbaslou, Massachusetts General Hospital; Farah R. W. Kools, Massachusetts General Hospital; Kritchai Vutipongsatorn, Massachusetts General Hospital; Xiaoyun Tong, Massachusetts General Hospital; Christina Gavegnano, Emory University; Raymond Schinazi, Emory University; Mark C. Poznansky, Massachusetts General Hospital
• Language: English
• Date: 2017-11-01
• Publisher: Impact Journals
• Publication Version: Final Published Version
• Copyright Statement: © 2018 Reeves et al.
• License: Creative Commons Attribution 3.0 Unported
• Final Published Version (URL): http://dx.doi.org/10.18632/oncotarget.25791
• Title of Journal or Parent Work: Oncotarget
• ISSN: 1949-2553
• Volume: 9
• Issue: 54
• Start Page: 30472
• End Page: 30472
• Keywords: tumor growth; Taxol; ovarian cancer; survival
• Research Categories: Health Sciences, Immunology; Health Sciences, Oncology

Abstract

This corrects the article DOI: 10.18632/oncotarget.21541. The corrected author name is given below: Christina Gavegnano